Indirect treatment comparison of bevacizumab + interferon-?-2a vs tyrosine ... - UroToday |
![]() |
UroToday ... in first-line metastatic renal-cell carcinoma (mRCC) therapy. These targeted therapies are currently competing to be primary choice; hence, in the absence of direct head-to-head comparison, there is a need for valid indirect comparison assessment. |